Food Science & Nutrition · Nov 14, 2026
Trimethylamine N‐Oxide ( TMAO ), Inflammation, and Cardiovascular Risk Factors in Adults With Overweight and Obesity: Impact of Fresh Watermelon Consumption in a Randomized Controlled Crossover Trial
By Bollish EM, Ager E, Santos ADL et al.
Elevated trimethylamine N‐oxide (TMAO) levels are associated with increased cardiovascular disease (CVD) risk. Watermelon consumption has been shown to improve cardiovascular function by favorably modulating lipid profiles and endothelial function. However, its impact on circulating TMAO levels remains unknown. This study examined the effects of daily watermelon consumption on TMAO and other cardiovascular risk markers in adults with overweight and obesity. In this randomized crossover clinical trial, 32 participants (16 men, 16 women; mean age 25.6 ± 6.0 years; mean BMI 29.0 ± 3.7 kg/m ² ) consumed 330 g/day of fresh watermelon (100 kcal) or an isocaloric control (low‐fat cookies, LFC) for 4 weeks, separated by a 4‐week washout period. Body weight and BMI changed numerically during the watermelon intervention, but these changes were not statistically significant ( p = 0.056 and p = 0.070, respectively). TMAO concentrations decreased significantly from baseline following watermelon consumption ( p = 0.005); however, the difference between the watermelon and LFC interventions at week 4 was not statistically significant ( p = 0.091). Triglycerides and LDL cholesterol were significantly reduced following the watermelon intervention ( p < 0.05). ICAM‐1 levels were numerically, but not statistically significantly, lower after watermelon consumption ( p = 0.083). Inflammatory markers TNF‐α and IL‐1β decreased significantly following the watermelon intervention ( p < 0.05). Total antioxidant capacity (TAC) increased compared to LFC ( p = 0.022). In conclusion, TMAO and selected cardiometabolic risk markers showed favorable within‐intervention changes during the watermelon period; however, the between‐intervention difference in TMAO was not statistically significant, although a numerical difference was observed. These exploratory findings require confirmation in larger, adequately powered studies. Trial Registration: The study was registered at clinicaltrials.gov (NCT 06323070)
doi.org/10.1002/fsn3.72587Open accessPubMed 43034810Interventions